For example, TP53 mutation can be an independent predictor of poor prognosis for NSCLC patients 25, and in lung adenocarcinoma, EGFR mutation is related to poor prognosis in patients 26. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.